Related Experiment Video
Updated: Jun 27, 2026

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
Published on: July 23, 2016
Porcine Erythrocyte-PRRSV Interactions: Implications for Targeted Nanodrug Delivery
Wei Yin1, Jingze Li1, Haoxiang Yao1
1Shanxi Key Laboratory for Modernization of TCVM, College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong 030801, China.
Insights
Researchers developed a targeted nanodrug delivery system for porcine reproductive and respiratory syndrome virus (PRRSV). This system utilizes porcine erythrocytes and CR1-like interactions to deliver matrine nanoliposomes, showing promise for PRRSV control.
Area of Science:
- Veterinary Virology
- Nanomedicine
- Immunology
Background:
- Porcine reproductive and respiratory syndrome virus (PRRSV) poses a significant threat to the swine industry.
- Understanding PRRSV infection mechanisms is crucial for developing effective control strategies.
- Erythrocytes play a role in immune responses and pathogen interactions.
Purpose of the Study:
- To establish a CR1-like-mediated targeted nanodrug delivery system for PRRSV.
- To investigate the interactions between porcine erythrocytes, PRRSV, and nanodrugs.
- To evaluate the efficacy of matrine nanoliposomes for PRRSV control.
Main Methods:
- Determined optimal conditions for PRRSV sensitization with porcine serum.
- Verified CR1-like-dependent immune adhesion of erythrocytes to PRRSV using microscopy and molecular techniques.
- Assessed the impact of this adhesion on PRRSV infection of porcine alveolar macrophages (PAMs).
- Prepared and characterized mannose-modified matrine nanoliposomes (MMLNPs) for in vitro evaluation.
Main Results:
- PRRSV sensitization was optimized under specific conditions (37°C, 2h).
- Porcine erythrocytes demonstrated specific CR1-like-mediated adhesion to sensitized PRRSV, enhancing PAM infection.
- Developed MMLNPs were stable, non-cytotoxic, and targeted PAMs via CR1-like.
- MMLNPs exhibited superior in vitro antiviral activity compared to free matrine.
Conclusions:
- CR1-like-mediated immune adhesion is a key mechanism in PRRSV infection of PAMs.
- Targeting this natural pathway allows for efficient delivery of nanodrugs to infected cells.
- This approach offers a promising strategy for developing novel PRRSV therapeutics.
Objective:
To establish a porcine complement receptor type 1-like (CR1-like)-mediated targeted anti-porcine reproductive and respiratory syndrome virus (PRRSV) nanodrug delivery system by investigating interactions between erythrocytes from Landrace piglets (both male and female), PRRSV, and anti-PRRSV nanodrugs.
Methods:
Optimal conditions for PRRSV sensitization with fresh porcine serum were determined. CR1-like-dependent immune adhesion of porcine erythrocytes to sensitized PRRSV was verified by immunofluorescence, electron microscopy, qPCR, and Western blot. The effect of this adhesion on PRRSV infection of porcine alveolar macrophages (PAMs) was studied using a flow chamber system. Mannose-modified matrine nanoliposomes (MMLNPs) were prepared, characterized, and evaluated for cytotoxicity, targeting ability, and in vitro antiviral activity.
Results:
PRRSV was optimally sensitized by incubation with fresh porcine serum at 37 °C for 2 h. Porcine erythrocytes specifically adhered to sensitized PRRSV via CR1-like, significantly promoting PRRSV infection of PAMs. Stable, uniform-sized MMLNPs showed no cytotoxicity, targeted PAMs via CR1-like, and exhibited superior antiviral activity to free matrine.
Conclusions:
CR1-like-mediated immune adhesion is a critical mechanism for PRRSV infection of PAMs. Harnessing this natural pathway enables efficient targeted delivery of matrine nanoliposomes to PAMs, providing a promising translational strategy for PRRSV control.
More Related Videos
04:18A Seamless Cloning Approach for Porcine Reproductive and Respiratory Syndrome Virus Expression Vector Construction
Published on: May 17, 2024
09:36Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo
Published on: February 5, 2019